<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03105427</url>
  </required_header>
  <id_info>
    <org_study_id>LeukoCAPE02</org_study_id>
    <nct_id>NCT03105427</nct_id>
  </id_info>
  <brief_title>Leukocytes and Cardiovascular Perioperative Events-2</brief_title>
  <acronym>LeukoCAPE-2</acronym>
  <official_title>Assoziationen Von Leukozyten-Sub-Populationen im Blut kardiovaskulärer Risikopatienten Mit Der Inzidenz Perioperativer kardiovaskulärer Ereignisse</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Heidelberg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Heidelberg</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The potential use of regulatory T cells as preoperative risk stratification tool is evaluated
      in order to improve clinical risk stratification and reduce perioperative morbidity and
      mortality.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Annually, there are more than 200 million surgeries worldwide. The POISE study revealed 5% of
      patients undergoing a non-cardiac surgery suffer perioperative myocardial infarcts going
      along with a perioperative mortality rate of about 11,6%. Possibilities to preoperatively
      identify patients at risk are limited and prophylactic interventions are not yet established
      or controversial.

      Selected leukocyte subpopulations have been demonstrated to be associated with higher risk
      for cardiovascular events.

      The aim of this study is to evaluate the potential use of regulatory T cells as preoperative
      risk stratification tool in order to improve clinical risk stratification and reduce
      perioperative morbidity and mortality. Therefore, high-risk cardiovascular patients scheduled
      for major non-cardiac surgery will be recruited. Blood will be drawn at predefined time
      points before surgery and up to three days postoperatively. Leukocytes will be analyzed by
      flow cytometry. During 30 day follow up adverse cardiovascular events will be recorded. ECGs
      will be recorded preoperatively and on post-OP day 3. High-sensitive cardiac Troponin T will
      be measured prior to the operation and on post-OP day one to three. The patient chart will be
      screened for cardiovascular events up to day 30. A telephone interview will be performed to
      detect cardiovascular events after discharge until post-OP day 30.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 10, 2017</start_date>
  <completion_date type="Actual">January 5, 2018</completion_date>
  <primary_completion_date type="Actual">January 5, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiovascular Events</measure>
    <time_frame>30 days postoperative</time_frame>
    <description>Number of participants with Cardiovascular Events defined as occurrence of Cardiac Death and/or Myocardial Ischemia and/or Myocardial Infarction and/or Myocardial Injury After Non-cardiac Surgery (MINS) and/or Embolic Stroke and/or Thrombotic Stroke recorded until postoperative day 30. Definitions according to European Perioperative Clinical Outcome-(EPCO) definitions detected at postoperative visits, documented in patient chart or detected during telephone interview after 30 postoperative days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Peripheral vascular occlusion</measure>
    <time_frame>30 days postoperative</time_frame>
    <description>Diagnosed by a radiologist based on the results of duplex ultrasonography, angiography or CT-angiography.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>New onset atrial fibrillation</measure>
    <time_frame>30 days postoperative</time_frame>
    <description>Number of participants with new electrocardiographic detection of atrial fibrillation in postoperative ECG and/or documented in patient charts</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute kidney injury</measure>
    <time_frame>30 days postoperative</time_frame>
    <description>Number of participants with acute kidney injury according to KDIGO guidelines</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Congestive heart failure</measure>
    <time_frame>30 days postoperative</time_frame>
    <description>Number of participants with congestive heart failure according to European Perioperative Clinical Outcome (EPCO) definitions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac death</measure>
    <time_frame>30 days postoperative</time_frame>
    <description>Number of participants with cardiac Death defined as death because of new myocardial infarction or ischemia, or atrial or ventricular arrhythmias, or cardiogenic pulmonary edema, or pulmonary embolism detected at postoperative visits, documented in patient chart or detected during telephone interview after 30 postoperative days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial Ischemia</measure>
    <time_frame>30 days postoperative</time_frame>
    <description>Number of participants with myocardial ischemia defined as new electrocardiographic detection of myocardial ischemia in ECG and/or documented in patient charts which will be screened up to 30 postoperative days and/or detected during telephone interview after 30 postoperative days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial Infarction</measure>
    <time_frame>30 days postoperative</time_frame>
    <description>Number of participants with Myocardial Infarction defined as an increase in serum cardiac biomarker values in combination with symptoms of ischemia or new/presumed new significant ST segment or T wave ECG changes or new left bundle branch block or development of pathological Q waves on ECG. Definition according to European Perioperative Clinical Outcome-(EPCO) definitions detected at postoperative visits, postoperative blood analyses, documented in patient chart or detected during telephone interview after 30 postoperative days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial Injury after Non-cardiac Surgery (MINS)</measure>
    <time_frame>30 days postoperative</time_frame>
    <description>Number of participants with MINS defined as raise in postoperative hs-cTNT (high sensitivity cardiac troponin T) jugded due to myocardial ischemia detected at postoperative visits, documented in patient chart or detected during telephone interview after 30 postoperative days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke</measure>
    <time_frame>30 days postoperative</time_frame>
    <description>Number of participants with embolic or thrombotic stroke defined cerebral event with persistent residual motor, sensory or cognitive dysfunction detected at postoperative visits, documented in patient chart or detected during telephone interview after 30 postoperative days</description>
  </secondary_outcome>
  <enrollment type="Actual">233</enrollment>
  <condition>Elective Non-cardiac Surgery</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted to University Hospital Heidelberg suffering coronary heart disease and
        scheduled for major non-cardiac surgery
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years or older

          -  Coronary heart disease

          -  Non-cardiac surgery

          -  Inpatient treatment

          -  Informed consent

        Exclusion Criteria:

          -  17 years of age or younger

          -  Known pregnancy or breastfeeding

          -  Missing informed consent

          -  Ambulatory or day-case surgery

          -  Emergency surgery

          -  Acute or chronic leukemia

          -  Current aplasia or leukopenia

          -  Current GM-CSF treatment

          -  Carotid artery surgery

          -  History of splenectomy

          -  Current intravenous or oral Cortisone treatment

          -  History of organ transplantation

          -  Current immunosuppressive medication

          -  Chemotherapy completed less than 14 days ago

          -  Entity which is part of the composite endpoint diagnosed within past 28 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Anaesthesiology, University Hospital Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <state>Baden-Württemberg</state>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Rogacev KS, Cremers B, Zawada AM, Seiler S, Binder N, Ege P, Große-Dunker G, Heisel I, Hornof F, Jeken J, Rebling NM, Ulrich C, Scheller B, Böhm M, Fliser D, Heine GH. CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography. J Am Coll Cardiol. 2012 Oct 16;60(16):1512-20. doi: 10.1016/j.jacc.2012.07.019. Epub 2012 Sep 19.</citation>
    <PMID>22999728</PMID>
  </reference>
  <reference>
    <citation>Berg KE, Ljungcrantz I, Andersson L, Bryngelsson C, Hedblad B, Fredrikson GN, Nilsson J, Björkbacka H. Elevated CD14++CD16- monocytes predict cardiovascular events. Circ Cardiovasc Genet. 2012 Feb 1;5(1):122-31. doi: 10.1161/CIRCGENETICS.111.960385. Epub 2012 Jan 11.</citation>
    <PMID>22238190</PMID>
  </reference>
  <reference>
    <citation>Devereaux PJ, Xavier D, Pogue J, Guyatt G, Sigamani A, Garutti I, Leslie K, Rao-Melacini P, Chrolavicius S, Yang H, Macdonald C, Avezum A, Lanthier L, Hu W, Yusuf S; POISE (PeriOperative ISchemic Evaluation) Investigators. Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: a cohort study. Ann Intern Med. 2011 Apr 19;154(8):523-8. doi: 10.7326/0003-4819-154-8-201104190-00003.</citation>
    <PMID>21502650</PMID>
  </reference>
  <reference>
    <citation>Devereaux PJ, Sessler DI. Cardiac Complications in Patients Undergoing Major Noncardiac Surgery. N Engl J Med. 2015 Dec 3;373(23):2258-69. doi: 10.1056/NEJMra1502824. Review.</citation>
    <PMID>26630144</PMID>
  </reference>
  <reference>
    <citation>Engelbertsen D, Andersson L, Ljungcrantz I, Wigren M, Hedblad B, Nilsson J, Björkbacka H. T-helper 2 immunity is associated with reduced risk of myocardial infarction and stroke. Arterioscler Thromb Vasc Biol. 2013 Mar;33(3):637-44. doi: 10.1161/ATVBAHA.112.300871. Epub 2013 Jan 10.</citation>
    <PMID>23307873</PMID>
  </reference>
  <reference>
    <citation>Gillmann HJ, Meinders A, Grohennig A, Larmann J, Bünte C, Calmer S, Sahlmann B, Rustum S, Aper T, Lichtinghagen R, Koch A, Teebken OE, Theilmeier G. Perioperative levels and changes of high-sensitivity troponin T are associated with cardiovascular events in vascular surgery patients. Crit Care Med. 2014 Jun;42(6):1498-506. doi: 10.1097/CCM.0000000000000249.</citation>
    <PMID>24584063</PMID>
  </reference>
  <reference>
    <citation>Kotfis K, Biernawska J, Zegan-Barańska M, Żukowski M. Peripheral Blood Lymphocyte Subsets (CD4+, CD8+ T Cells, NK Cells) in Patients with Cardiovascular and Neurological Complications after Carotid Endarterectomy. Int J Mol Sci. 2015 May 4;16(5):10077-94. doi: 10.3390/ijms160510077.</citation>
    <PMID>25946343</PMID>
  </reference>
  <reference>
    <citation>Rogacev KS, Seiler S, Zawada AM, Reichart B, Herath E, Roth D, Ulrich C, Fliser D, Heine GH. CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease. Eur Heart J. 2011 Jan;32(1):84-92. doi: 10.1093/eurheartj/ehq371. Epub 2010 Oct 12.</citation>
    <PMID>20943670</PMID>
  </reference>
  <reference>
    <citation>Weiser TG, Regenbogen SE, Thompson KD, Haynes AB, Lipsitz SR, Berry WR, Gawande AA. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet. 2008 Jul 12;372(9633):139-44. doi: 10.1016/S0140-6736(08)60878-8. Epub 2008 Jun 24.</citation>
    <PMID>18582931</PMID>
  </reference>
  <reference>
    <citation>Weiser TG, Haynes AB, Molina G, Lipsitz SR, Esquivel MM, Uribe-Leitz T, Fu R, Azad T, Chao TE, Berry WR, Gawande AA. Size and distribution of the global volume of surgery in 2012. Bull World Health Organ. 2016 Mar 1;94(3):201-209F. doi: 10.2471/BLT.15.159293.</citation>
    <PMID>26966331</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 8, 2017</study_first_submitted>
  <study_first_submitted_qc>April 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 10, 2017</study_first_posted>
  <last_update_submitted>January 29, 2018</last_update_submitted>
  <last_update_submitted_qc>January 29, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Heidelberg</investigator_affiliation>
    <investigator_full_name>Johann Motsch</investigator_full_name>
    <investigator_title>Prof. Dr. med. habil.</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

